Getting lots of media attention. An analyst on CNBC was just talking about how the weight loss market has really come on in the last year. He expected NOVO with OZEMPIC/WEGOVY going against LLY Mounjaro to become very interesting. He also commented that there was a drug from Viking (VKTX) that could become a player. He didn't mention any other company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.